Sweden
· Delayed Price · Currency is SEK Spermosens AB Statistics
Total Valuation
Spermosens AB has a market cap or net worth of SEK 10.58 million. The enterprise value is 8.54 million.
| Market Cap | 10.58M |
| Enterprise Value | 8.54M |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Spermosens AB has 1.36 billion shares outstanding. The number of shares has increased by 1,152.08% in one year.
| Current Share Class | 1.36B |
| Shares Outstanding | 1.36B |
| Shares Change (YoY) | +1,152.08% |
| Shares Change (QoQ) | +378.19% |
| Owned by Insiders (%) | 6.40% |
| Owned by Institutions (%) | 2.52% |
| Float | 1.27B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.73 |
Financial Position
The company has a current ratio of 5.23, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.23 |
| Quick Ratio | 5.23 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -19.91 |
Financial Efficiency
Return on equity (ROE) is -38.60% and return on invested capital (ROIC) is -19.12%.
| Return on Equity (ROE) | -38.60% |
| Return on Assets (ROA) | -16.90% |
| Return on Invested Capital (ROIC) | -19.12% |
| Return on Capital Employed (ROCE) | -21.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.02M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.16% in the last 52 weeks. The beta is -0.38, so Spermosens AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.38 |
| 52-Week Price Change | -95.16% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 42.66 |
| Average Volume (20 Days) | 6,857,723 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.62M |
| Pretax Income | -9.06M |
| Net Income | -9.06M |
| EBITDA | -8.44M |
| EBIT | -8.62M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 2.12 million in cash and 83,000 in debt, giving a net cash position of 2.04 million or 0.00 per share.
| Cash & Cash Equivalents | 2.12M |
| Total Debt | 83,000 |
| Net Cash | 2.04M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 38.10M |
| Book Value Per Share | 0.03 |
| Working Capital | 3.09M |
Cash Flow
In the last 12 months, operating cash flow was -7.05 million and capital expenditures -4.60 million, giving a free cash flow of -11.64 million.
| Operating Cash Flow | -7.05M |
| Capital Expenditures | -4.60M |
| Free Cash Flow | -11.64M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Spermosens AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,152.08% |
| Shareholder Yield | -1,152.08% |
| Earnings Yield | -85.60% |
| FCF Yield | -110.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |